Meno a priezvisko:
|
prof. RNDr. Ján Lehotský, DrSc.
|
Typ dokumentu:
|
Vedecko/umelecko-pedagogická charakteristika osoby
|
Názov vysokej školy:
|
Univerzita Komenského v Bratislave
|
Sídlo vysokej školy:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Zamestnanie-pracovné zaradenie | III.b - Inštitúcia | III.c - Časové vymedzenie |
---|---|---|
Vedecky aspirant | SAV | 1977-79 |
odb asistent | Univ Komenskeho, Jeseniova lek fak Martin | 1980-89 |
docent | Univ Komenskeho, Jeseniova lek fak Martin | 1990-2001 |
profesor | Univ Komenskeho, Jeseniova lek fak Martin | 2002-doteraz |
IV.a - Popis aktivity, názov kurzu (ak išlo o kurz), iné | IV.b - Názov inštitúcie | IV.c - Rok |
---|---|---|
lek chémia | Univ Komenskeho, Jeseniova lek fak Martin | 1980-doteraz |
Med biochem | Univ Komenskeho, Jeseniova lek fak Martin | 1980-doteraz |
Patobiochemia | Univ Komenskeho, Jeseniova lek fak Martin | 2000-doteraz |
V.1.a - Názov profilového predmetu | V.1.b - Študijný program | V.1.c - Stupeň | V.1.d - Študijný odbor |
---|---|---|---|
Lek chemia | Lek chemia | doktorsky | vseob. lekártsvo |
Lek Biochemia | Lek biochemia | doktorsky | Vseob lek |
Patobiochemia | Patobiochemia | doktorsky | Vseob lek |
V.2.a - Názov študijného programu | V.2.b - Stupeň | V.2.c - Študijný odbor |
---|---|---|
Lek biochemia | doktorsky | vseob lek |
Patobiochemia | doktorsky | Vseob lek |
V.3.a - Názov odboru habilitačného konania a inauguračného konania | V.3.b - Študijný odbor, ku ktorému je priradený |
---|---|
Lekarska, klinicka a farmaceuticka biochemie | Vseob lek |
VEGA 213/12 Project brings a novel insight on the ethiology of CNS damage by neurotoxicant -homocystein
as well as on the mechanisms
of ichemicj tolerance and its interference with naturally present toxicant. The pathways of MAP kinases have
been described
in the endogenous processes of tolerance evolution by preconditioning. It has been found that homocysteine
neurotoxicity is
partially suppressed by ischemic toleranci. The results originally extent the knowledge on the effect of
hyperhomocysteinémia
to the phenomenon of ischemic tolerance and can be perspectively utilized in the praxis. The detailed
knowledge on this
phenomenon could have a clinical impact to the procedure linked with the short term ischemia or transient
ischemic atack.
VEGA 128/16: Project brings a novel insight on the ethiology of CNS damage by neurotoxicant -
homocystein as well as on the mechanisms of ichemicj tolerance and its interference with naturally present
toxicant. The pathways of MAP kinases have been described
in the endogenous processes of tolerance evolution by preconditioning. It has been found that homocysteine
neurotoxicity is
partially suppressed by ischemic toleranci. The results originally extent the knowledge on the effect of
hyperhomocysteinémia
to the phenomenon of ischemic tolerance and can be perspectively utilized in the praxis. The detailed
knowledge on this
phenomenon could have a clinical impact to the procedure linked with the short term ischemia or transient
ischemic atack
VEGA 230/20 Protective role of vitamin D in the development of EAE, animal model of SM, defined by
neurologic scores and changes in the proteomic profile and levels o f neurotrometabolites analyzed by
MRS. Lower levels of vitamin D in patients serum with SM.
Quocient of light chain of immunoglobulines ?-fLC in liquor and serum has a diagnostic characteristics with
high sensitivity,
suitable also for routine praxis. We found association of HLA-DRB1 and DQB1 allel and genotype
polymorphisms with the
onset of diseases and progression of disability( EDSS scores).Allele DRB1*07 is positive and DRB1*15/15 a
DQB1*03/*03
are clinically negative prognostic factors. Polymorphisms of genes for vitamín D associate with HLA
complex (rs703842 in
CYP27B1). We have optimalized process of dealbuminization for proteomic analysis of plasma a by
metabolomic and MRS
studies we have indentified level changes of metabolites of Krebs cycle , amino acids and changes in
glutamate
VEGA project 274/23 : Project includes experiments which describe complex effect of modifiable risk factors
- neurotoxic substances in
combination with cerebral ischemic-reperfusion damageon laboratory animals and impact of this
combination on
manifestation of functional, vascular changes and neurodegenerative processes. Study of molecular,
biochemical, spectroskopic and immunohistologic changes induced by risk factors and their combination
with
cerebral ischemia with the aim to identify ethiologic mechanisms perspectively utilizable in human praxis.
APVV project 15/107: Integrating translational and clinical research which by biological and molecular
approach enables a more
detailed understanding of the role of vitamine D and other markers in relation to the development and
progression of sclerosis multiplex. By application of
this approach, from the level of animal model of SM - experimental allergic encephalomyelitis to clinically
diagnosed group of SM patients, to improve patients stratification, identification of predisposed individuals,
personalization of the prevention and therapy.
Characterization of origin and progression of demyelinization prognosis in correlation with the plasma level
of
vitamine D or its metabolites. Determination of linkage and validity of genetic markers and gene
polymorphisms
in correlation to
the disease progression. Analysis of the influence of vitamine D and its derivatives on genetic DNA
modifications
and micro RNA
expression in model and in patients with various disability progression (MSSS scores). By proteomic and
MR
and MRS analyses to
quantify damage and to understand in more details the role of vitamine D and its derivatives in the disease
ADC_022 / Škovierová, Henrieta (Autor) [UKOLJ110A] (25%) - Vidomanová, Eva (Autor) [UKOLJ110A]
(15%) - Mahmood, Silvia (Autor) (15%) - Pálešová, Janka (Autor) [Interný doktorand] [UKOLJ111] (10%) -
Drgová, Anna (Autor) [UKOLJ111] (10%) - Červeňová, Tatiana (Autor) (5%) - Halašová, Erika (Autor)
[UKOLJ120] (10%) - Lehotský, Ján (Autor) [UKOLJ111] (10%): The Molecular and Cellular Effect of
Homocysteine Metabolism Imbalance on Human Health. – DOI 10.3390/ijms17101733. – CCC ; SCO ;
WOS CC ; SCIE.
In: International journal of molecular sciences [textový dokument (print)] [elektronický dokument] . – Bazilej
(Švajčiarsko) : Multidisciplinary Digital Publishing Institute. – ISSN 1661-6596. – ISSN (online) 1422-0067. –
Roč. 17, č. 10 (2016), art. no. 1733, s. [1-18] [online] [tlačená forma]
Počet všetkých autorov: 8
[článok]
Lit.: 112
[OV 180 Lekárske, farmaceutické a nelekárske zdravotnícke vedy]
Indikátor časopisu:
IF: 3,226 - 2016
SNIP: 1,157 - 2016
SJR: 1,235 - 2016
CiteScore: 5,4 - 2016
Kvartil Q (2016):
JIF - Biochemistry & molecular biology - Q2 JIF - Chemistry, multidisciplinary - Q2
Cited : 304
APVV -15/107 - Role of vitamine D and other markers in the progression of multiple
sclerosis
VEGA 274/23- Effect of neurotoxicants as risk factors on the onset and progression of CNS vascular
disorders
VIII.a - Názov inštitúcie | VIII.b - Sídlo inštitúcie | VIII.c - Obdobie trvania pôsobenia/pobytu (uviesť dátum odkedy dokedy trval pobyt) | VIII.d - Mobilitná schéma, pracovný kontrakt, iné (popísať) |
---|---|---|---|
COST EU - DC BMBC European Union 2002-2014 | European Union | 2002-2014 | |
Catholic University Leuven, Belgium Leuven, Belgium | Leuven, | 1990-91, 1993, 1996, 1998 | NATO research grant, National belgium grant IX. - |